The role of circulating endothelial progenitor cells in tumor angiogenesis

Current Stem Cell Research and Therapy

Volumn 6, Issue 2, 2011, Pages 115-121

  Mund, Julie A ^a,b   Case, Jamie ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; Hematopoiesis; Murine endothelial progenitor cell; Myeloid cells; Tumor angiogenesis

Indexed keywords

CD31 ANTIGEN; CD34 ANTIBODY; CD45 ANTIGEN; ENDOGLIN; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; BONE MARROW CELL; CARCINOGENESIS; CELL LINEAGE; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; VASCULAR ENDOTHELIUM;

ADULT; ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 79955698682     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811795495468     Document Type: Article

References (57)

1. Nolan DJ, Ciarrocchi A, Mellick AS, et al. Bone marrow-derivedendothelial progenitor cells are a major determinant of nascent tu-mor neovascularization. Genes Dev 2007; 21(12): 1546-58.
2. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch inmouse lung metastasis. Science 2008; 319(5860): 195-8.
3. Ciarrocchi A, Jankovic V, Shaked Y, et al. Id1 restrains p21 e-xpression to control endothelial progenitor cell formation. PLoSOne 2007; 2(12): e1338.
4. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exoge-nous genes to tumor angiogenesis by transplantation of geneticallymodified hematopoietic stem cells. Nat Med 2003; 9(6): 789-95.
5. De Palma M, Mazzieri R, Politi LS, et al. Tumor-targeted interfe-ron-alpha delivery by Tie2-expressing monocytes inhibits tumorgrowth and metastasis. Cancer Cell 2008; 14(4): 299-311.
6. Kerbel RS, Benezra R, Lyden DC, et al. Endothelial progenitorcells are cellular hubs essential for neoangiogenesis of certain ag-gressive adenocarcinomas and metastatic transition but not adeno-mas. Proc Natl Acad Sci USA 2008; 105(34): E54; author replyE55.
7. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cellsblocks tumor angiogenesis and growth. Nat Med 2001; 7(11):1194-201.
8. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor responseto radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300(5622): 1155-9.
9. Machein MR, Renninger S, de Lima-Hahn E, Plate KH. Minorcontribution of bone marrow-derived endothelial progenitors to thevascularization of murine gliomas. Brain Pathol 2003; 13(4): 582-97.
10. Gothert JR, Gustin SE, van Eekelen JA, et al. Genetically taggingendothelial cells in vivo: bone marrow-derived cells do not contri-bute to tumor endothelium. Blood 2004; 104(6): 1769-77.
11. Shaked Y, Ciarrocchi A, Franco M, et al. Therapy-induced acuterecruitment of circulating endothelial progenitor cells to tumors. Science 2006; 313(5794): 1785-7.
12. Ruzinova MB, Schoer RA, Gerald W, et al. Effect of angiogenesisinhibition by Id loss and the contribution of bone-marrow-derivedendothelial cells in spontaneous murine tumors. Cancer Cell 2003;4(4): 277-89.
13. Purhonen S, Palm J, Rossi D, et al. Bone marrow-derived circula-ting endothelial precursors do not contribute to vascular endothe-lium and are not needed for tumor growth. Proc Natl Acad SciUSA 2008; 105(18): 6620-5.
14. Slayton WB, Li XM, Butler J, et al. The role of the donor in therepair of the marrow vascular niche following hematopoietic stemcell transplant. Stem Cells 2007; 25(11): 2945-55.
15. Urao N, Inomata H, Razvi M, et al. Role of nox2-based NADPHoxidase in bone marrow and progenitor cell function involved inneovascularization induced by hindlimb ischemia. Circ Res 2008;103(2): 212-20.
16. Qin G, Ii M, Silver M, et al. Functional disruption of alpha4 inte-grin mobilizes bone marrow-derived endothelial progenitors andaugments ischemic neovascularization. J Exp Med 2006; 203(1):153-63.
17. Ruifrok WP, de Boer RA, Iwakura A, et al. Estradiol-induced,endothelial progenitor cell-mediated neovascularization in malemice with hind-limb ischemia. Vasc Med 2009; 14(1): 29-36.
18. Asahara T, Murohara T, Sullivan A, et al. Isolation of putativeprogenitor endothelial cells for angiogenesis. Science 1997;275(5302): 964-7.
19. Huber TL, Kouskoff V, Fehling HJ, Palis J, Keller G. Haemangio-blast commitment is initiated in the primitive streak of the mouseembryo. Nature 2004; 432(7017): 625-30.
20. Guthrie SM, Curtis LM, Mames RN, Simon GG, Grant MB, Scott EW. The nitric oxide pathway modulates hemangioblast activity ofadult hematopoietic stem cells. Blood 2005; 105(5): 1916-22.
21. Sengupta N, Caballero S, Mames RN, Butler JM, Scott EW, andGrant MB. The role of adult bone marrow-derived stem cells inchoroidal neovascularization. Invest Ophthalmol Vis Sci 2003;44(11): 4908-13.
22. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stemcells provide functional hemangioblast activity during retinal neo-vascularization. Nat Med 2002; 8(6): 607-12.
23. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, andLacaud G. The haemangioblast generates haematopoietic cellsthrough a haemogenic endothelium stage. Nature 2009; 457(7231):892-5.
24. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. Runx1 is required for the endothelial to haematopoietic cell transi-tion but not thereafter. Nature 2009; 457(7231): 887-91.
25. Eilken HM, Nishikawa S, Schroeder T. Continuous single-cellimaging of blood generation from haemogenic endothelium. Nature 2009; 457(7231): 896-900.
26. Bertrand JY, Chi NC, Santoso B, Teng S, Stainier DY, Traver D.Haematopoietic stem cells derive directly from aortic endotheliumduring development. Nature 2010; 464(7285): 108-11.
27. Kissa K, Herbomel P. Blood stem cells emerge from aortic endo-thelium by a novel type of cell transition. Nature 2010; 464(7285):112-5.
28. Shaked Y, Henke E, Roodhart JM, et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implicationsfor antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008; 14(3): 263-73.
29. Bailey AS, Willenbring H, Jiang S, et al. Myeloid lineage progeni-tors give rise to vascular endothelium. Proc Natl Acad Sci USA 2006; 103(35): 13156-61.
30. Monestiroli S, Mancuso P, Burlini A, et al. Kinetics and viabilityof circulating endothelial cells as surrogate angiogenesis marker inan animal model of human lymphoma. Cancer Res 2001; 61(11):4341-4.
31. Shaked Y, Bertolini F, Man S, et al. Genetic heterogeneity of thevasculogenic phenotype parallels angiogenesis; Implications forcellular surrogate marker analysis of antiangiogenesis. Cancer Cell 2005; 7(1): 101-11.
32. Bertolini F, Mancuso P, Kerbel RS. Circulating endothelial proge-nitor cells. N Engl J Med 2005; 353(24): 2613-6; author reply2613-6.
33. Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifacetedcirculating endothelial cell in cancer: towards marker and target i-dentification. Nat Rev Cancer 2006; 6(11): 835-45.
34. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008; 358(19):2039-49.
35. Mancuso P, Calleri A, Cassi C, et al. Circulating endothelial cellsas a novel marker of angiogenesis. Adv Exp Med Biol 2003; 522:83-97.
36. Bertolini F, Paul S, Mancuso P, et al. Maximum tolerable dose andlow-dose metronomic chemotherapy have opposite effects on themobilization and viability of circulating endothelial progenitorcells. Cancer Res 2003; 63(15): 4342-6.
37. Capillo M, Mancuso P, Gobbi A, et al. Continuous infusion ofendostatin inhibits differentiation, mobilization, and clonogenic po-tential of endothelial cell progenitors. Clin Cancer Res 2003; 9(1):377-82.
38. Somani A, Nguyen J, Milbauer LC, Solovey A, Sajja S, Hebbel RP. The establishment of murine blood outgrowth endothelial cellsand observations relevant to gene therapy. Transl Res 2007; 150(1):30-9.
39. Milbauer LC, Enenstein JA, Roney M, et al. Blood outgrowthendothelial cell migration and trapping in vivo: a window into genetherapy. Transl Res 2009; 153(4): 179-89.
40. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial pro-genitor cells via clonal analysis and hematopoietic stem/progenitorcell principals. Blood 2007; 109(5): 1801-9.
41. Salter AB, Meadows SK, Muramoto GG, et al. Endothelial proge-nitor cell infusion induces hematopoietic stem cell reconstitution invivo. Blood 2009; 113(9): 2104-7.
42. Hooper AT, Butler JM, Nolan DJ, et al. Engraftment and reconsti-tution of hematopoiesis is dependent on VEGFR2-mediated rege-neration of sinusoidal endothelial cells. Cell Stem Cell 2009; 4(3):263-74.
43. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progeni-tor cells for neovascularization. Nat Med 1999; 5(4): 434-8.
44. Lewis CE, De Palma M, Naldini L. Tie2-expressing monocytes andtumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res 2007; 67(18): 8429-32.
45. De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hemato-poietic lineage of proangiogenic monocytes required for tumor ves-sel formation and a mesenchymal population of pericyte progeni-tors. Cancer Cell 2005; 8(3): 211-26.
46. Li H, Gerald WL, Benezra R. Utilization of bone marrow-derivedendothelial cell precursors in spontaneous prostate tumors varieswith tumor grade. Cancer Res 2004; 64(17): 6137-43.
47. Dudley AC, Udagawa T, Melero-Martin JM, et al. Bone marrow isa reservoir for pro-angiogenic myelomonocytic cells but not endo-thelial cells in spontaneous tumors. Blood 2010; 116(17): 3367-71.
48. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularizationof ischemic myocardium by human bone-marrow-derived angio-blasts prevents cardiomyocyte apoptosis, reduces remodeling andimproves cardiac function. Nat Med 2001; 7(4): 430-6.
49. Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatalneovascularization with autologous bone marrow transplantation. Circulation 2001; 103(6): 897-903.
50. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin ofendothelial progenitor cells responsible for postnatal vasculogene-sis in physiological and pathological neovascularization. Circ Res 1999; 85(3): 221-8.
51. Jin DK, Shido K, Kopp HG, et al. Cytokine-mediated deploymentof SDF-1 induces revascularization through recruitment ofCXCR4+ hemangiocytes. Nat Med 2006; 12(5): 557-67.
52. Furstenberger G, von Moos R, Lucas R, et al. Circulating endothe-lial cells and angiogenic serum factors during neoadjuvant chemo-therapy of primary breast cancer. Br J Cancer 2006; 94(4): 524-31.
53. Demirer T, Rowley S, Buckner CD, et al. Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombi-nant human granulocyte colony-stimulating factor in patients withbreast and ovarian cancer. J Clin Oncol 1995; 13(7): 1714-9.
54. Srour EF, Yoder MC. Flow cytometric analysis of hematopoieticdevelopment. Methods Mol Med 2005; 105: 65-80.
55. Holmes C, Stanford WL. Concise review: stem cell antigen-1:expression, function, and enigma. Stem Cells 2007; 25(6): 1339-47.
56. Reber L, Da Silva CA, Frossard N. Stem cell factor and its receptorc-Kit as targets for inflammatory diseases. Eur J Pharmacol 2006;533(1-3): 327-40.
57. Hobson B, Denekamp J. Endothelial proliferation in tumours andnormal tissues: continuous labelling studies. Br J Cancer 1984;49(4): 405-13.